Some residents will only need one dose of the COVID-19 vaccine with the arrival of a third vaccine option in American Samoa.
They are getting the new Janssen vaccine (also known as the Johnson & Johnson vaccine), which is a one shot treatment unlike the Pfizer and Moderna products which require two doses.
The territory received its first shipment of Jansen vaccines, 600, last Saturday.
Janssen will be offered to those who find it difficult to come in for the second shot, like 18-25 year olds, bed ridden people or those who will be traveling.
The COVID-19 Task Force is looking at using these doses for those travelling on repatriation flights or for individuals who have difficulty returning or acquiring the second shots of Pfizer and Moderna.
As of March 30, 53.8% of the eligible population has received at least one dose of the COVID-19 vaccine while 41.7% have completed two shots.
Dept. of Health (DOH) data shows that 53.5% of the 41-50 age group, 54.9% of the 51-60 age group, and 58.8% of the 61 and older age group are now fully vaccinated with two-shots.
In its latest press release, the Task Force said, “This is very positive news for the territory’s vaccination efforts because the risk for severe illness with COVID-19 increases with age, with older adults at highest risk.”
In other news, the Task Force has decided to charge $150 for every COVID -19 test it administers to non-US citizens and nationals at the seaport.
The move is an effort to cover costs for testing as well as services provided at the seaport and follows a recommendation by the Dept. of Health.
